Comment: Baxter’s Gambro deal gives EC first look at dialysis markets
Baxter’s planned takeover of Swedish dialysis firm Gambro may face a fairly smooth review at the European Commission, if the regulator concludes that the two firms are active in different dialysis...To view the full article, register now.
Already a subscriber? Click here to view full article